Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23232310 | 0.68 | SMN1; SMN2 (0.38) | CNR2EPHX2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL12166403 | 0.67 | CHRM2 (0.42) | RAB9AGAAHPGD | |
| SCHEMBL14947616 | 0.67 | SLC6A2 (0.32) | CNR2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2481307 | 0.66 | L3MBTL1 (0.36) | CNR2EPHX2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL14950736 | 0.65 | KDM4E (0.35) | CNR2EPHX2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL15349095 | 0.64 | CNR2 (0.36) | CNR2SLC6A2SLC6A4SLC6A3RAB9A | |
| SCHEMBL2507068 | 0.61 | HPGD (0.36) | SLC6A2SLC6A4SLC6A3RAB9AHPGD | |
| SCHEMBL697727 | 0.59 | TP53 (0.42) | CNR2EPHX2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL17726044 | 0.57 | — | — | |
| SCHEMBL5376501 | 0.57 | SMN1; SMN2 (0.40) | CNR2SLC6A2SLC6A4SLC6A3RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2086995-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2012-02-22 | — | — | EP | disclosed |